The US Food and Drug Administration (FDA) has authorised Pfizer’s antiviral pill, Paxlovid, to treat COVID-19.
This is the first antiviral COVID-19 pill authorised for sick people to take at home before they are sick enough to be hospitalised.
Paxlovid combines a new antiviral drug named nirmatrelvir and an older one called ritonavir and is administered as three pills given twice a day for five days.
In a statement on Wednesday, the FDA said those eligible for the pill include high-risk individuals age 12 and older who weigh at least 88 pounds and have a positive SARS-CoV-2 test are eligible.
It said Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said the pill is a major step forward in the fight against this global pandemic.
READ ALSO! Nigerian Central Bank Approves Disbursement Of Loans For Creative Industries At 9%
READ ALSO! Tony Elumelu To Empower 1,000 Northern Entrepreneurs With $5000 Each
READ ALSO! How To Empower Yourself And Generate Income From Mutual Funds
READ ALSO! Is N-Power Truly Empowering Nigerian Youths?
READ ALSO! How Nigerian Govt Can Lift 100million People Out Of Poverty — Tony Elumelu
READ ALSO! TraderMoni: Poverty Alleviation Or Political Leverage?
READ ALSO! Is N-Power Truly Empowering Nigerian Youths?
READ ALSO! Gtbank 737 Disservice: How to Kick Your Customers in the Butt!
READ ALSO! Why The North Remains Headquarters Of Poverty In Nigeria — Kingsley Moghalu
READ ALSO! The Love Of Your Life Is An Illusion: It Doesn’t Exist Anywhere!
